Recurrent ovarian cancer treatments don't just fight the disease—they also affect how patients feel daily. To measure this, doctors use patient-reported outcomes (PROs), which are feedbacks directly from patients about their symptoms and quality of life. But are these tools reliable enough, especial
The idea of a group of specialists reviewing cancer data is not new, but how it actually helps patients with ovarian cancer has been unclear. In a recent study, researchers looked at real‑world outcomes for two types of serous ovarian cancer: the aggressive high‑grade form and the slower low‑grade v
Women who have endometriosis, especially ovarian cysts called endometriomas, face about twice the chance of developing ovarian cancer compared to those without the condition. The overall risk over a lifetime is still small, roughly 2 percent. Studies show that the same gene changes—ARID1A, PIK
Women fighting advanced ovarian cancer often face a tough battle with malnutrition. This isn't just about feeling weak or tired; it can make treatments harder to handle and slow down recovery after surgery. But here's a bright spot: doctors are now looking at ways to help women get stronger before t
A recent court case in California has left Johnson & Johnson with a hefty price tag. A jury decided that the company should pay $40 million to two women who claimed that using the company's baby powder led to their ovarian cancer. The women, Monica Kent and Deborah Schultz, both used the product fo
Ovarian cancer is a serious health issue. It affects many women, especially those who are older. A recent study took a close look at this problem. It focused on women aged 65 and above. The goal was to understand how this cancer behaves in older women. Also, it looked at how they are treated and wha
Bevacizumab, a drug that targets blood vessel growth, is being looked at closely for its potential to help people with advanced ovarian cancer. This isn't just any study; it's based on real-world data from a German cancer registry, making it more relatable and practical. The focus is on patients wi
PD-L1 is a protein that can interfere with the immune system's ability to function properly. Some researchers believe it might play a significant role in epithelial ovarian cancer (EOC). However, there's still a lot of uncertainty about how PD-L1 affects treatment outcomes or if it's linked to resis
Ariana DeBose is going through a tough time right now. Her mother, Gina DeBose, passed away on August 17th. She was 57 years old. The cause of her death was complications from stage 3 ovarian cancer. Ariana shared this sad news on her Instagram on August 19th. Gina was more than just a mom to Arian
Ovarian cancer treatment often involves surgery followed by chemotherapy. But when should the chemo start? This is a big question. A recent study looked into this. It wanted to see how the time between surgery and chemo affects survival rates. First, the basics. Ovarian cancer is serious. Surgery i
